bpharm limited
bpharm limited Company Information
Company Number
04470974
Next Accounts
Sep 2025
Industry
Other human health activities
Directors
Shareholders
miss bhavnivenichand bajwa
Group Structure
View All
Contact
Registered Address
10 coledale drive, stanmore, middlesex, HA7 2QF
Website
www.wringtons.co.ukbpharm limited Estimated Valuation
Pomanda estimates the enterprise value of BPHARM LIMITED at £19.3k based on a Turnover of £35.1k and 0.55x industry multiple (adjusted for size and gross margin).
bpharm limited Estimated Valuation
Pomanda estimates the enterprise value of BPHARM LIMITED at £0 based on an EBITDA of £-403 and a 4.21x industry multiple (adjusted for size and gross margin).
bpharm limited Estimated Valuation
Pomanda estimates the enterprise value of BPHARM LIMITED at £8.6k based on Net Assets of £3.5k and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Bpharm Limited Overview
Bpharm Limited is a live company located in middlesex, HA7 2QF with a Companies House number of 04470974. It operates in the other human health activities sector, SIC Code 86900. Founded in June 2002, it's largest shareholder is miss bhavnivenichand bajwa with a 100% stake. Bpharm Limited is a mature, micro sized company, Pomanda has estimated its turnover at £35.1k with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Bpharm Limited Health Check
Pomanda's financial health check has awarded Bpharm Limited a 0.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 8 areas for improvement. Company Health Check FAQs
0 Strong
2 Regular
8 Weak
Size
annual sales of £35.1k, make it smaller than the average company (£832k)
- Bpharm Limited
£832k - Industry AVG
Growth
3 year (CAGR) sales growth of 4%, show it is growing at a slower rate (6.4%)
- Bpharm Limited
6.4% - Industry AVG
Production
with a gross margin of 34.4%, this company has a comparable cost of product (34.4%)
- Bpharm Limited
34.4% - Industry AVG
Profitability
an operating margin of -1.2% make it less profitable than the average company (5.6%)
- Bpharm Limited
5.6% - Industry AVG
Employees
with 1 employees, this is below the industry average (20)
1 - Bpharm Limited
20 - Industry AVG
Pay Structure
on an average salary of £26.2k, the company has an equivalent pay structure (£26.2k)
- Bpharm Limited
£26.2k - Industry AVG
Efficiency
resulting in sales per employee of £35.1k, this is less efficient (£49.5k)
- Bpharm Limited
£49.5k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Bpharm Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (16 days)
- Bpharm Limited
16 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Bpharm Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 65 weeks, this is less cash available to meet short term requirements (103 weeks)
65 weeks - Bpharm Limited
103 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 78.5%, this is a higher level of debt than the average (26.4%)
78.5% - Bpharm Limited
26.4% - Industry AVG
BPHARM LIMITED financials
Bpharm Limited's latest turnover from December 2023 is estimated at £35.1 thousand and the company has net assets of £3.5 thousand. According to their latest financial statements, Bpharm Limited has 1 employee and maintains cash reserves of £16.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | |||||||||||||||
| Tax | |||||||||||||||
| Profit After Tax | |||||||||||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | |||||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | ||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 95 | 119 | 149 | 186 | 232 | 290 | 362 | 452 | 565 | 628 | 785 | 1,047 | 1,118 | 1,491 | 1,359 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 95 | 119 | 149 | 186 | 232 | 290 | 362 | 452 | 565 | 628 | 785 | 1,047 | 1,118 | 1,491 | 1,359 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 286 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 6,244 | 5,000 | 5,050 | 10,293 | 4,614 | 0 | 0 | 0 | 0 | 14 | 11 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 37 | 358 | 35 | 34 | 34 | 6,095 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 16,098 | 17,752 | 16,152 | 12,245 | 3,061 | 1,703 | 1,103 | 5,730 | 7,769 | 18,849 | 18,820 | 26,462 | 7,015 | 26,187 | 20,183 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 16,135 | 18,110 | 16,187 | 12,279 | 9,339 | 13,084 | 6,153 | 16,023 | 12,383 | 18,849 | 18,820 | 26,462 | 7,015 | 26,201 | 20,194 |
| total assets | 16,230 | 18,229 | 16,336 | 12,465 | 9,571 | 13,374 | 6,515 | 16,475 | 12,948 | 19,477 | 19,605 | 27,509 | 8,133 | 27,692 | 21,553 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 22 | 112 | 184 | 90 | 0 | 0 | 79 | 0 | 12,264 | 4,481 | 0 | 0 | 0 | 12,726 | 7,053 |
| Group/Directors Accounts | 11,948 | 14,218 | 12,628 | 8,991 | 6,226 | 9,854 | 3,185 | 13,929 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 655 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 777 | 762 | 762 | 573 | 561 | 530 | 428 | 361 | 0 | 0 | 3,395 | 7,237 | 5,613 | 0 | 0 |
| total current liabilities | 12,747 | 15,092 | 13,574 | 9,654 | 6,787 | 11,039 | 3,692 | 14,290 | 12,264 | 4,481 | 3,395 | 7,237 | 5,613 | 12,726 | 7,053 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 12,747 | 15,092 | 13,574 | 9,654 | 6,787 | 11,039 | 3,692 | 14,290 | 12,264 | 4,481 | 3,395 | 7,237 | 5,613 | 12,726 | 7,053 |
| net assets | 3,483 | 3,137 | 2,762 | 2,811 | 2,784 | 2,335 | 2,823 | 2,185 | 684 | 14,996 | 16,210 | 20,272 | 2,520 | 14,966 | 14,500 |
| total shareholders funds | 3,483 | 3,137 | 2,762 | 2,811 | 2,784 | 2,335 | 2,823 | 2,185 | 684 | 14,996 | 16,210 | 20,272 | 2,520 | 14,966 | 14,500 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 24 | 30 | 37 | 46 | 58 | 72 | 90 | 113 | 63 | 157 | 262 | 349 | 373 | 497 | 454 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | |||||||||||||||
| Stock | 0 | 0 | 0 | 0 | -286 | 286 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -321 | 323 | 1 | -6,244 | -4,817 | 6,045 | -5,243 | 5,679 | 4,614 | 0 | 0 | 0 | -14 | 3 | 11 |
| Creditors | -90 | -72 | 94 | 90 | 0 | -79 | 79 | -12,264 | 12,264 | 4,481 | 0 | 0 | -12,726 | 5,673 | 7,053 |
| Accruals and Deferred Income | 15 | 0 | 189 | 12 | 31 | 102 | 67 | 361 | -3,395 | -3,395 | -3,842 | 1,624 | 5,613 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -2,270 | 1,590 | 3,637 | 2,765 | -3,628 | 6,669 | -10,744 | 13,929 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | -655 | 655 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | |||||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | -1,654 | 1,600 | 3,907 | 9,184 | 1,358 | 600 | -4,627 | -2,039 | -11,051 | 29 | -7,642 | 19,447 | -19,172 | 6,004 | 20,183 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -1,654 | 1,600 | 3,907 | 9,184 | 1,358 | 600 | -4,627 | -2,039 | -11,051 | 29 | -7,642 | 19,447 | -19,172 | 6,004 | 20,183 |
bpharm limited Credit Report and Business Information
Bpharm Limited Competitor Analysis
Perform a competitor analysis for bpharm limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in HA7 area or any other competitors across 12 key performance metrics.
bpharm limited Ownership
BPHARM LIMITED group structure
Bpharm Limited has no subsidiary companies.
Ultimate parent company
BPHARM LIMITED
04470974
bpharm limited directors
Bpharm Limited currently has 1 director, Mrs Bhavni Bajwa serving since Jun 2002.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Bhavni Bajwa | United Kingdom | 48 years | Jun 2002 | - | Director |
P&L
December 2023turnover
35.1k
+1%
operating profit
-427.2
0%
gross margin
34.5%
-2.38%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
3.5k
+0.11%
total assets
16.2k
-0.11%
cash
16.1k
-0.09%
net assets
Total assets minus all liabilities
Similar Companies
bpharm limited company details
company number
04470974
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
June 2002
age
22
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
N/A
accountant
LPTA LIMITED
auditor
-
address
10 coledale drive, stanmore, middlesex, HA7 2QF
Bank
-
Legal Advisor
-
bpharm limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to bpharm limited.
bpharm limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BPHARM LIMITED. This can take several minutes, an email will notify you when this has completed.
bpharm limited Companies House Filings - See Documents
| date | description | view/download |
|---|
